Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer
Clinical trial NCT01152801 · COMPLETED
Trial details
- NCT number
- NCT01152801
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2013-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.